Jeffrey Friedland
Directeur Général chez Friedland Global Capital Pte. Ltd.
Postes actifs de Jeffrey Friedland
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Friedland Global Capital Pte. Ltd. | Directeur Général | - | - |
| Corporate Officer/Principal | 01/01/1979 | - | |
| Global Corporate Strategies LLC | Directeur Général | 01/01/2011 | - |
Cannrx Technology, Inc.
 Cannrx Technology, Inc. Medical SpecialtiesHealth Technology CannRx Technology, Inc. is a private company that specializes in developing scientifically-based proprietary cannabis technologies. CannRx Technology, Inc. is based in New York, NY. The company's focus is on creating transformative technology that delivers more effective, higher bioavailability, scientifically formulated cannabis products. The company has developed patented, breakthrough technologies that will transform the cannabis industry. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Jeffrey Friedland
Anciens postes connus de Jeffrey Friedland
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| NEXIEN BIOPHARMA, INC. | Directeur/Membre du Conseil | - | 07/03/2018 |
| Directeur Général | - | 07/03/2018 | |
| CHINA GENGSHENG MINERALS, INC. | Directeur/Membre du Conseil | 01/07/2013 | 12/05/2014 |
Israel Plant Sciences Ltd.
 Israel Plant Sciences Ltd. Agricultural Commodities/MillingProcess Industries Israel Plant Sciences Ltd. is a holding Israeli company with subsidiaries that specialize in cannabis breeding, plant breeding support software development, and medicinal extraction from cannabis. The company is based in Herzliya, Israel. and has subsidiaries in Canada. The company was founded in 2015 by Jeffrey Friedland and Oded Sagee. | Fondateur | 24/11/2015 | - |
Kinder Holding Corp.
 Kinder Holding Corp. Financial ConglomeratesFinance Kinder Holding Corp. engages in the research and development of cannabis cannabinoid-based drugs for various medical conditions and disorders. It focuses on identifying the appropriate compounds for its myotonic and muscular diseases drug candidate. The company was founded on November 10, 1952 and is headquartered in San Marino, CA. | Directeur/Membre du Conseil | 13/10/2017 | - |
| Directeur Général | 13/10/2017 | - | |
| Friedland Capital Equity Research LLC | Corporate Officer/Principal | 01/01/1979 | - |
| President | - | - |
Formation de Jeffrey Friedland
| The University of Colorado | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
| Chine | 2 |
| Singapour | 2 |
Opérationnelle
| Director/Board Member | 4 |
| Chief Executive Officer | 4 |
| Corporate Officer/Principal | 2 |
Sectorielle
| Finance | 3 |
| Health Technology | 3 |
| Non-Energy Minerals | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CHINA GENGSHENG MINERALS, INC. | Non-Energy Minerals |
| NEXIEN BIOPHARMA, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
| Friedland Capital Equity Research LLC | Finance |
| Friedland Global Capital Pte. Ltd. | |
| Global Corporate Strategies LLC | |
Kinder Holding Corp.
Kinder Holding Corp. Financial ConglomeratesFinance Kinder Holding Corp. engages in the research and development of cannabis cannabinoid-based drugs for various medical conditions and disorders. It focuses on identifying the appropriate compounds for its myotonic and muscular diseases drug candidate. The company was founded on November 10, 1952 and is headquartered in San Marino, CA. | Finance |
Israel Plant Sciences Ltd.
Israel Plant Sciences Ltd. Agricultural Commodities/MillingProcess Industries Israel Plant Sciences Ltd. is a holding Israeli company with subsidiaries that specialize in cannabis breeding, plant breeding support software development, and medicinal extraction from cannabis. The company is based in Herzliya, Israel. and has subsidiaries in Canada. The company was founded in 2015 by Jeffrey Friedland and Oded Sagee. | Process Industries |
Cannrx Technology, Inc.
Cannrx Technology, Inc. Medical SpecialtiesHealth Technology CannRx Technology, Inc. is a private company that specializes in developing scientifically-based proprietary cannabis technologies. CannRx Technology, Inc. is based in New York, NY. The company's focus is on creating transformative technology that delivers more effective, higher bioavailability, scientifically formulated cannabis products. The company has developed patented, breakthrough technologies that will transform the cannabis industry. | Health Technology |
- Bourse
- Insiders
- Jeffrey Friedland
- Expérience
